Latest Listings And Ipos News

Veris Limited has expanded its relationship with Hexagon’s Octave by becoming the authorised geospatial software distributor across Australia and New Zealand, aiming to generate an initial $1.2 million in annual recurring revenue.

Holista Colltech’s shares remain suspended on the ASX following a trading halt linked to ongoing legal issues with ProImmune Company LLC, with no resolution in sight.

AIS Resources has commenced a detailed helicopter-borne magnetic survey over Riversgold’s Saint John Gold/Copper/Silver/Antimony Project in New Brunswick, aiming to sharpen drill targets ahead of 2026 exploration drilling.

Pointerra has landed a three-year, A$0.4 million deal with Western Power to roll out its Pointerra3D digital twin platform across transmission substations in Western Australia, marking a significant foothold in the domestic energy utility sector.

49 Metals Limited has secured $10 million through its IPO to fund a detailed exploration campaign in Nevada’s Walker Lane Trend, including an 8,000-metre drilling program at the Gold Mountain project targeting high-grade gold zones.

Vectus Biosystems has completed the sale of its VB4-P5 renal fibrosis compound to Canadian biotech XORTX, receiving a near 10% equity stake and warrants. This move aligns with Vectus’ strategy to develop drug candidates to a stage attractive to partners while focusing on its lead compound VB0004.

Vita Resources has completed a $100,000 capital raise via a placement featuring a novel partly paid share class designed specifically for mining companies. This new share structure defers calls until at least 2030, offering investors flexibility and the company a unique capital management tool.

Green Cross Health (NZX: GXH) has acknowledged discussions with third parties about a possible sale of its Medical division but emphasised that no transaction is guaranteed. The company remains committed to updating shareholders as the situation develops.

Insignia Financial Limited will be removed from the S&P/ASX 200 Index ahead of its acquisition by Daintree BidCo, with 4DMedical Limited stepping in on April 20, 2026.

Ariadne Australia’s latest nine-month update reveals strong growth in its Orams subsidiary but a $5.2 million estimated total loss driven by currency headwinds and market declines in key investments.

Surefire Resources NL acknowledged a week-long delay in announcing CEO Dr Andrew Whitehead's resignation, citing transition uncertainties and promising tighter disclosure controls.

Cadence Opportunities Fund weathered a sharp March selloff to deliver a robust 35.9% gain for the 2026 financial year so far, while announcing a fully franked interim dividend of 7.5 cents per share.